Skip to main content
oAv Menu
Home
Patient Care Center
Clinical Trials
Providers
Therapeutics
People
Places
Community Center
Community Stories
Social Media
Community Content
Financial Assistance
News
Community Events
Clinical Trials and Research
Business
News People
Happenings
Spotlight
Fundraising Events
Trusted Resources
Education
Videos & Visuals
Event Calendar
Login
Search
BridgeBio secures $300 million from royalty financing, enhancing its financial position for Attruby® launch and pipeline development.
News
Serum amyloid P secreted by bone marrow adipocytes drives skeletal amyloidosis
Jul 29, 2025
AstraZeneca therapy for clearing protein deposits fails main goal in late-stage study
Jul 16, 2025
AstraZeneca’s AL amyloidosis drug fails to reduce mortality in phase 3 test
Jul 16, 2025
Challenges in Diagnosing Systemic Amyloidosis
Jul 16, 2025
Incidence and prevalence of light chain amyloidosis in the United States in 2019–2021 using Optum EHR data
Jul 11, 2025
More in News
Education
Educational attainment, electroencephalographic rhythms, cortical structure, and cognitive performance over 2 years in older adults with subjective memory complaints and brain amyloidosis
Jul 14, 2025
Tolerability and efficacy of sodium-glucose co-transporter 2 inhibitors in patients with cardiac amyloidosis: a meta-analysis of observational studies
Jul 07, 2025
Cytological Diagnosis of Amyloidosis From Orbital Papules
Jul 01, 2025
Amyloid Light-Chain (AL) Amyloidosis in a Middle-Aged Lady: Confronting the Challenges of a Rare Diagnosis in a Developing Country
Jun 07, 2025
Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis
Jun 02, 2025
More in Education
Community Center
Confirming the Benefit of SGLT2 Inhibitors in People With ATTR Amyloidosis, with Justin Riley Lam, MD
Apr 05, 2025
Dottie’s Travel Alert for TAVR Patients
Apr 02, 2025
Advance Insulin Injection Technique and Education With FITTER Forward Expert Recommendations
Apr 01, 2025
Alnylam Presents New Data from the HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM) at the American College of Cardiology’s Annual Scientific Session 2025
Mar 31, 2025
Connecting with amyloidosis patients and caregivers in N.Z.
Mar 12, 2025
More in Community Center
Hot Topics
Healthy Meal Planning: Tips for Older Adults
Mar 12, 2025
An Elderly Mother and an Aging Son: A Journalist’s Caregiving Story
Mar 07, 2025
Supporting Family Caregivers in Providing Care
Mar 04, 2025
Live-In Caregivers for Elderly
Feb 26, 2025
The Hidden Cost of Caregiving: Stress, Anxiety, and Coping Mechanisms
Jan 23, 2025
Video